PLC Systems, Inc. (PLCSF) Approved by Japanese Military of Health, Labor, and Welfare to Commence Clinical Trial
PLC Systems, a medical device company focused on innovative technologies for the cardiac and vascular markets, reports that the Japanese Ministry of Health, Labor, and Welfare (MHLW) has approved the initiation of a clinical trial in Japan using the company’s RenalGuard Therapy®. The approval follows a thorough review of previously published studies of RenalGuard Therapy as well as of data from two cases where Japanese physicians used RenalGuard® to protect patients at risk of Contrast-Induced Acute Kidney Injury (CI-AKI). RenalGuard is currently CE-Marked and being distributed throughout Europe to prevent AKI. "We are very excited to begin clinical studies with…